查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197527

醫用氣體和設備市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)

Medical Gases and Equipment Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 111 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

醫用氣體和設備市場預計在預測期內 (2022-2027) 以 8.1% 的複合年增長率增長。

醫用氣體在醫療保健中有多種用途。 例如，有的氣體用於麻醉，有的用於驅動醫療設備和工具，有的用於治療。

COVID-19 大流行將廣泛影響所研究的市場。 2021年，由於各國醫療機構缺乏醫用氧氣，許多人死亡。 這導致對純醫用氣體的高需求，促進了市場的增長。 世界衛生組織 (WHO) 2021 年 7 月的數據估計，在第二波冠狀病毒大流行期間，低收入和中等收入國家將有超過 50 萬人每天需要氧氣治療。 數據還顯示，需要9000萬美元的應急基金來滿足20多個中低收入國家的緊急氧氣需求。 數據顯示，在 COVID-19 期間，對醫用氧氣的需求很高。 因此，市場受到這種大流行的積極影響。

推動醫用氣體和設備市場增長的其他關鍵因素包括對家庭保健和即時診斷的需求增加、呼吸系統疾病負擔增加以及政府組織的有利舉措。您可以 慢性呼吸道疾病 (CRD) 是氣道和肺部其他結構的慢性疾病。 常見的肺部疾病包括哮喘、慢性阻塞性肺病、職業性肺病和肺動脈高壓。

根據世界衛生組織 (WHO) 2022 年 5 月更新的數據，每年有超過 300 萬人死於慢性阻塞性肺病 (COPD)，這是全球死亡人數。估計佔人口的 6%，據說約有 2.35 億人患有哮喘病。 世界衛生組織估計，到 2030 年，COPD 將成為全球第三大死因。 雖然這些病症無法治愈，但各種治療方法可以通過打開呼吸道和改善呼吸急促來改善患有這些病症的人的生活質量。

氧氣療法用於一些慢性肺部疾病，COPD 就是其中之一。 氧氣用於減輕心臟負擔，而不是肺部。 有助於預防肺動脈高壓。 長期吸氧可以減輕心臟的負擔。 其他醫用氣體也用於治療各種慢性呼吸系統疾病，呼吸系統疾病的上升趨勢正在成為醫用氣體和設備市場增長的驅動因素。

醫用氣體和設備市場趨勢

預計純醫用氣體細分市場在預測期內將呈現良好增長

純醫用氣體的子部分預計增長最快，因為氧氣是所有現代麻醉技術和機械通氣患者生命支持的基石。 世界上慢性病患病率的增加和交通事故的發生是推動市場增長的主要因素。 入住重症監護病房和門診進行各種手術的患者需要氧氣來維持生命。 氧氣源分為兩類：散裝氧氣系統和鋼瓶歧管供應系統。

2021 年將出現第二波 COVID-19，對氧氣的需求將猛增。 例如，正如世界銀行的一篇文章所述，印度安裝了 3,500 多台變壓吸附 (PSA) 制氧機，其中 1,200 多台由印度總理領導的 PM Care Fund 解決，以應對醫療挑戰。信件。 預計這些努力將推動該部門的增長。

Compliant Healthcare Technologies, LLC 宣布廣泛使用純醫用氣體，例如醫用空氣、氧氣、氮氣、二氧化碳和一氧化二氮。 由於對醫用氣體及其在醫療保健中的重要性的認識不斷加深，該市場在全球範圍內蓬勃發展。

北美預計將佔據最大的市場份額

北美在醫用氣體和設備市場中佔有很大份額，預計在預測期內將呈現類似趨勢，不會出現大的波動。 這種穩定的增長率主要是由於越來越多地使用醫用氣體和設備來管理各種呼吸系統疾病，例如慢性阻塞性肺病和哮喘。

根據美國疾病控制與預防中心 (CDC) 的數據，到 2021 年，將有大約 3400 萬美國人患有慢性阻塞性肺病。 預計在預測期內，慢性阻塞性肺病和哮喘等不斷上升的醫療狀況以及心血管和生活方式疾病將推動美國對醫用氣體和設備的需求。

特別是，重症監護病房等最先進醫療設施的存在、醫用氣體市場的建立、大量呼吸系統疾病患者以及不斷增長的老年人口是最大的貢獻者美國市場份額。 在美國，家庭氧療的使用正在增加，醫用氣體的標準、分析和供應方法正在現代化。

因此，在上述因素的背景下，醫用氣體市場有望在預測期內實現高速增長。

醫用氣體和設備市場競爭者分析

由於少數主要參與者的存在，醫用氣體和設備市場適度集中。 Air Liquide、Air Products & Chemicals、Amico Group、Atlas Copco、Beacon Medes、Linde Group、Flowgas、Messer Group GmbH、Matheson Trigas 和 Taiyo Nippon Sanso Corporation 只是一些例子。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 對家庭保健和即時診斷的需求不斷增長
    • 呼吸道疾病增加
    • 政府機構的積極努力
  • 市場製約因素
    • 嚴格的監管流程
    • 有限的醫療報銷
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分

  • 按產品分類
    • 醫用氣體
      • 純醫用氣體
      • 醫用混合氣體
      • 生物大氣層
    • 醫用氣體設備
      • 壓縮機
      • 氣缸
      • 軟管總成和閥門
      • 面具
      • 真空系統
      • 其他醫用氣體設備
  • 最終用戶
    • 醫院
    • 門診護理
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Air Liquide
    • Air Products and Chemicals Inc.
    • Amico Group of Companies
    • Atlas Copco
    • BeaconMedaes
    • Flogas
    • Matheson Tri-Gas Inc.
    • Messer Group GmbH
    • Taiyo Nippon Sanso Corporation
    • The Linde Group

第7章 市場機會今後動向

簡介目錄
Product Code: 50695

The medical gases and equipment market is projected to register a CAGR of 8.1% over the forecast period (2022-2027). Medical gases are used for various purposes in healthcare. For instance, some gases are used for anesthesia, some for driving medical devices and tools, and some gases are used in treatment.

COVID-19 pandemic has a wide impact on the market studied. In the year 2021, a large number of people died due to the lack of medical oxygen in a healthcare facilities in various countries. This contributed to the high demand for pure medical gases and helped grow the market. As per the July 2021 data from the World Health Organization, more than half a million people in lower-to-middle-income countries were estimated to need oxygen treatment every day during the second wave of the coronavirus pandemic. Also, the same data suggests that USD 90 million in immediate funding was required to meet the urgent need for oxygen in more than 20 low-and-middle-income countries. The data indicate that medical gas oxygen was in high demand during COVID-19. Hence, the market was positively impacted as a result of the pandemic.

Other major factors driving the growth of the medical gases and equipment market include the rising demand for home healthcare and point-of-care diagnostics, the increasing burden of respiratory diseases, and favorable initiatives undertaken by government organizations. Chronic respiratory diseases (CRDs) are chronic diseases of the airways and other structures of the lung. Common lung diseases include asthma, chronic obstructive pulmonary disease, occupational lung diseases, and pulmonary hypertension.

According to the World Health Organization (WHO) data updated in May 2022, more than 3 million people die each year from chronic obstructive pulmonary disease (COPDs), an estimated 6% of all deaths worldwide, and about 235 million people are suffering from asthma. WHO estimates COPD to become the third leading cause of death globally by 2030. Though these are not curable, various forms of treatment help dilate air passages and improve shortened breath and increase the quality of life for people suffering from these diseases.

Oxygen therapy is used for some chronic lung conditions, and COPD is one of these conditions. Oxygen is used to take the strain off one's heart, not lungs. It helps in preventing pulmonary artery hypertension. Long-term oxygen use can help relieve the strain on the heart. Other medical gases are also used to treat different chronic respiratory conditions, and the increasing prevalence of respiratory diseases acts as a driver for the growth of the medical gases and equipment market.

Medical Gases & Equipment Market Trends

The Pure Medical Gases Sub-segment is Expected to Show Good Growth over the Forecast Period

The pure medical gas sub-segment is expected to be the fastest-growing segment, owing to the large usage of oxygen gas, as the oxygen gas provides a base for all modern anesthetic techniques and life support for artificially ventilated patients. The rising incidence of chronic diseases and road accidents across the world are major factors boosting the growth of the market. The patients admitted to intensive care units and ambulatory care for various types of surgeries require oxygen gas for life support. The oxygen supply sources are divided into two categories, namely bulk oxygen systems and cylinder-manifold-supply systems.

During the year 2021, the second wave of COVID-19 arose during which, demand for oxygen hiked drastically. For instance, as stated in the article by World Bank 2022, more than 3,500 Pressure swing adsorption (PSA) oxygen generating plants are being installed in India among which over 1,200 are from the PM Care Fund, an initiative of the Prime Minister of India to cope with healthcare challenges. Such initiatives are expected to propel the growth of the segment.

As stated by Compliant Healthcare Technologies, LLC, some of the widely used pure medical gases include Medical air, Oxygen, Nitrogen, Carbon dioxide, and Nitrous Oxide, among others. Owing to the rising understanding of medical gases and their importance in healthcare, the market studied is growing rapidly across the globe.

North America is Expected to Account for the Largest Market Share

North America held a major share in the medical gases and equipment market, and it is expected to show a similar trend over the forecast period, without significant fluctuations. This steady growth rate is majorly attributed to the increasing use of medical gases and equipment in the management of various respiratory diseases, such as COPD and asthma.

As stated by the Center for Disease Control and Prevention (CDC), as of the year 2021, there are around 34 million US people who suffer from COPD. The growing incidences of COPD, asthma, and other medical conditions, such as cardiovascular and lifestyle-related diseases, are expected to drive the demand for medical gases and equipment in the United States, during the forecast period.

The presence of state-of-the-art healthcare facilities, especially intensive care units, a well-established medical gas market, a high prevalence of patients with respiratory disorders, and the growing geriatric population have contributed to the largest share of the United States market. In the United States, the medical gas sector is in the middle of a shift in standards, analysis, and delivery procedures, which results from the current increase in the use of home oxygen therapy to the modernization of medical gas standards and the means of supply.

Therefore, with the above-mentioned factors, the market for medical gases is expected to witness high growth over the forecast period.

Medical Gases & Equipment Market Competitor Analysis

The market studied is moderately consolidated, owing to the presence of a few key players in the market. Some of the market players are Air Liquide, Air Products and Chemicals Inc., Amico Group of Companies, Atlas Copco, BeaconMedaes, the Linde Group, Flogas, Messer Group GmbH, Matheson Tri-Gas Inc., and Taiyo Nippon Sanso Corporation.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Demand for Home Healthcare and Point-of-care Diagnostics
    • 4.2.2 Increasing Prevalence of Respiratory Diseases
    • 4.2.3 Favorable Initiatives Undertaken by Government Organizations
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Process
    • 4.3.2 Limited Healthcare Reimbursement
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Medical Gases
      • 5.1.1.1 Pure Medical Gases
      • 5.1.1.2 Medical Gas Mixtures
      • 5.1.1.3 Biological Atmosphere
    • 5.1.2 Medical Gas Equipment
      • 5.1.2.1 Compressors
      • 5.1.2.2 Cylinders
      • 5.1.2.3 Hose Assemblies and Valves
      • 5.1.2.4 Masks
      • 5.1.2.5 Vacuum Systems
      • 5.1.2.6 Other Medical Gas Equipment
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Care
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Air Liquide
    • 6.1.2 Air Products and Chemicals Inc.
    • 6.1.3 Amico Group of Companies
    • 6.1.4 Atlas Copco
    • 6.1.5 BeaconMedaes
    • 6.1.6 Flogas
    • 6.1.7 Matheson Tri-Gas Inc.
    • 6.1.8 Messer Group GmbH
    • 6.1.9 Taiyo Nippon Sanso Corporation
    • 6.1.10 The Linde Group

7 MARKET OPPORTUNITIES AND FUTURE TRENDS